🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the efficacy, safety and tolerabili...
Status
Terminated
Location
University of Connecticut Health Center
Start Date
2017-07-18
Trial ID
NCT03234465
This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-06-11
Trial ID
NCT06953999
This is an efficacy and safety study to compare aprepitant with ondansetron...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-12
Trial ID
NCT01636947
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
This is a double-blind, randomized, placebo-controlled, parallel study. The...
Status
Unknown
Location
Chung-Ho Memorial Hospital, Kaohsiung Medical University:
Start Date
2018-11-09
Trial ID
NCT04342949
Treatments Being Tested
The purpose of this study is to assess if adding revumenib to standard chem...
Status
Recruiting
Location
Clinical Trial Site
Start Date
2025-11-25
Trial ID
NCT07211958
Treatments Being Tested
This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Status
Recruiting
Location
The fourth hospital of Hebei Medical University
Start Date
2024-11-15
Trial ID
NCT06576921
Treatments Being Tested
The purpose of this study is to investigate the ability of alvimopan to red...
Status
Terminated
Location
UCSD Moores Cancer Center
Start Date
2018-03-08
Trial ID
NCT03352414
The GI-4000 therapeutic vaccine or placebo will be injected under the skin ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2006-01
Trial ID
NCT00300950
Treatments Being Tested
This was a multicenter, randomized, double-blind, phase III trial. This cli...
Status
Completed
Location
Jiangsu hengrui medicine CO. LTD
Start Date
2014-03-26
Trial ID
NCT02329860